Lake Bleu Capital logo

Lake Bleu Capital

Asia, Hong Kong Island, Hong Kong, Hong Kong

Description

Lake Bleu Capital is a Hong Kong-based investment platform that specializes in healthcare.

Investor Profile

Lake Bleu Capital has made 14 investments, with 1 in the past 12 months and 21% as lead.

Stage Focus

  • Series C (21%)
  • Series D (21%)
  • Series E (14%)
  • Post Ipo Equity (7%)
  • Series Unknown (7%)
  • Private Equity (7%)
  • Series B (7%)
  • Series A (7%)
  • Seed (7%)

Country Focus

  • China (71%)
  • United States (21%)
  • Hong Kong (7%)

Industry Focus

  • Biotechnology
  • Health Care
  • Pharmaceutical
  • Therapeutics
  • Medical
  • Artificial Intelligence (Ai)
  • Product Research
  • Beauty
  • Hospital
  • Biopharma
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Lake Bleu Capital frequently co-invest with?

OrbiMed
North America, New York, United States, New York
Co-Investments: 8
CICC
Asia, Beijing, China, Beijing
Co-Investments: 2
GIC
Asia, Central Region, Singapore, Singapore
Co-Investments: 2
Baidu Ventures
Asia, Beijing, China, Beijing
Co-Investments: 2
Warburg Pincus
Europe, Madrid, Spain, Boadilla Del Monte
Co-Investments: 2
HongShan
Asia, Beijing, China, Beijing
Co-Investments: 2
Qiming Venture Partners
Asia, Shanghai, China, Shanghai
Co-Investments: 2
CPE
Asia, Beijing, China, Beijing
Co-Investments: 2
Lilly Asia Ventures
Asia, Shanghai, China, Shanghai
Co-Investments: 4
Janchor Partners
Asia, Hong Kong Island, Hong Kong, Central
Co-Investments: 3

What are some of recent deals done by Lake Bleu Capital?

Expedition Therapeutics

San Francisco, California, United States

Expedition Therapeutics operates as an unincorporated association.

Biotechnology
SeedMar 20, 2025
Bang Er Orthopedic

Hangzhou, Zhejiang, China

Bang Er Orthopedic is a Hangzhou based healthcare company.

Health CareMedical
Series ENov 9, 2023
Amount Raised: $109,840,320
Tongxin Medical Equipment

Suzhou, Jiangsu, China

Tongxin Medical Equipment is an artificial-heart maker company.

Biotechnology
Series DJan 25, 2022
Amount Raised: $100,000,000
GenFleet Therapeutics

Shanghai, Shanghai, China

GenFleet Therapeutics is a biotechnology developer and researcher of molecular pharmaceuticals targeting cancer treatments.

BiotechnologyHealth CareOncologyPharmaceutical
Series CDec 31, 2021
Amount Raised: $78,667,065
Insilico Medicine

Hong Kong, Hong Kong Island, Hong Kong

Insilico Medicine develops an AI platform for drug development to treat cancer and age-related diseases.

Artificial Intelligence (AI)BiotechnologyHealth CarePharmaceutical
Series CJun 22, 2021
Amount Raised: $255,000,000
Biocytogen

Daxing, Beijing, China

Biocytogen is a biopharmaceutical company that provides integrated solutions for antibody drug development.

BiotechnologyHealth CareMedical DeviceTherapeutics
Series EJun 22, 2021
AffaMed Therapeutics

New City, New York, United States

AffaMed Therapeutics is a biopharmaceutical company focused on developing and commercializing transformative pharmaceutical products.

Biotechnology
Series BMar 30, 2021
Amount Raised: $170,000,000
Brii Biosciences

Durham, North Carolina, United States

Brii Biosciences is a biotechnology company that commits to bring innovative medicines to China as a way to improve public health.

BiotechnologyHealth CareInnovation ManagementPharmaceutical
Series CMar 23, 2021
Amount Raised: $155,000,000
Abbisko Therapeutics

Shanghai, Shanghai, China

Abbisko Therapeutics is a drug company dedicated to innovative drug research and development.

Health CarePharmaceuticalTherapeutics
Series DJan 7, 2021
Amount Raised: $123,000,000
Ruipeng Pet Healthcare

Shenzhen, Guangdong, China

Ruipeng Pet Hospital is a Shenzhen-based pet medical and beauty care hospital operator.

BeautyHealth CareHospitalMedical
Series UnknownSep 29, 2020